Dr. Reddy's Laboratories, Inc. 13D and 13G filings for Coya Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-12 2:52 pm Purchase | 2026-01-30 | 13G | COYA THERAPEUTICS INC COYA | Dr. Reddy's Laboratories, Inc. | 2,272,727 9.700% | 2,272,727 (New Position) | Filing |